Dermatofibrosarcoma protuberans

LAST UPDATED: Jun 26, 2023

Introduction

Dermatofibrosarcoma protuberans (DFSP) is a rare, locally invasive, slow-growing tumour of the subcutaneous tissue that recurs frequently after surgical excision. Despite its name, DFSP is regarded as a low-grade tumour, however, careful histological evaluation is necessary as a small proportion of lesions develop a high-grade fibrosarcomatous component.

This chapter is set out as follows:


History

  • DFSP has an annual incidence of only 4.2 cases per million
  • It tends to present in young to middle-aged adults with a slight female predominance
  • There may be a prior history of trauma, burn or previous surgery

Clinical findings

Distribution

  • The tumour most frequently involves the trunk (42-72%), the proximal extremities (16%-30%), and the head and neck (10-16%) especially the scalp

Morphology

  • The initial presentation of DFSP is a single, raised, red to bluish, firm, cutaneous nodule or plaque
  • Overlying the tumour the skin surface can be brown-yellow, red-tinged, sclerodermiform or telangiectatic 
  • Lesions grow very slowly to form irregular, protuberant swellings 
  • DFSP is extremely infiltrative and has a locally destructive growth pattern that can invade the underlying structures such as fascia, muscle and bone
  • At advanced stages, the tumour can ulcerate, bleed and become painful

Clinical Images

Please refer to notes on image rights at bottom of the page with regards to individual image ownership.


Management

  • Management is in Secondary Care, treatment is with a wide local excision of between 2-4 cm, or Mohs micrographic surgery 
  • Local recurrence is not uncommon, and can occur many years later. Metastatic spread is uncommon, and is perhaps confined to those tumours that have developed a high-grade fibrosarcomatous component

Disclaimer - the author PCDS cannot accept responsibility for any misleading or incorrect statements, and the management of individual patients remains the direct responsibility of the individual doctor. We do however hope that visitors to this site can contact us regarding comments that are considered misleading or incorrect so that we can continue to improve the site.

Image Rights - The PCDS would like to thank Dermatoweb, DermQuest (Galderma), and others who have contributed images. All named individuals and organisations maintain copyright for the relevant images.

Quick Links

The following pharmaceutical companies have had no involvement in the content of this website or in our conference programmes

Almirall
Galderma
Glenmark
Johnson & Johnson
La Roche-Posay
LEO Pharma
Pierre Fabre
Schuco